Who Paid My Doc
Samir Hamati
Urogynecology and Reconstructive Pelvic Surgery Spring Lake, MI Medical Doctor
NPI 1225050552 CMS profile 282742
17208 Van Wagoner Rd, Ste 2700, Spring Lake, MI 49456
General payments
$2,535
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Samir Hamati of Spring Lake, MI is reported in the CMS Open Payments database as having received $2,535 across 27 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 20th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $228 | 7 | |
| 2021 | General | $167 | 5 | |
| 2020 | General | $1,469 | 11 | |
| 2019 | General | $671 | 4 |
Beside peers
- Samir Hamati
- Urogynecology and Reconstructive Pelvic Surgery median
- Middle half of Urogynecology and Reconstructive Pelvic Surgery
- National median
In program year 2025, general payments to Samir Hamati were reported at $0. Among 149 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $779 and the middle half received between $301 and $2,705.
Show as a table
| Year | Samir Hamati | Urogynecology and Reconstructive Pelvic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $671 | $799 | $319–$2,013 | $163 |
| 2020 | $1,469 | $384 | $158–$1,360 | $114 |
| 2021 | $167 | $641 | $247–$2,515 | $132 |
| 2022 | $228 | $843 | $347–$2,794 | $149 |
| 2023 | $0 | $819 | $308–$2,302 | $160 |
| 2024 | $0 | $882 | $306–$2,459 | $164 |
| 2025 | $0 | $779 | $301–$2,705 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
26
Drug cost
$6,637
Branded share of claims
46.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Premarin Estrogens, Conjugated | Brand | 12 | $5,548 | |
| Estradiol | Generic | 14 | $1,089 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.
Records
27 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Urogynecology and Reconstructive Pelvic Surgery in Michigan
Priyanka Gupta
Urogynecology and Reconstructive Pelvic Surgery · Ann Arbor, MI
Melissa Fischer
Urogynecology and Reconstructive Pelvic Surgery · Royal Oak, MI
Anne Cameron
Urogynecology and Reconstructive Pelvic Surgery · Brighton, MI
Gabrielle Rohrer
Urogynecology and Reconstructive Pelvic Surgery · Royal Oak, MI
Pradeep Nagaraju
Urogynecology and Reconstructive Pelvic Surgery · Royal Oak, MI
Giulia Ippolito
Urogynecology and Reconstructive Pelvic Surgery · Ann Arbor, MI
Related records
Urogynecology and Reconstructive Pelvic Surgery in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Urogynecology and Reconstructive Pelvic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.